Department of Pathology and Laboratory Medicine, UNC Blood Research Center, University of North Carolina, Chapel Hill, North Carolina, USA.
J Thromb Haemost. 2023 Nov;21(11):3005-3015. doi: 10.1016/j.jtha.2023.08.014. Epub 2023 Aug 23.
Fibrinogen is an extraordinary molecule by any estimation. It is large, structurally intricate, and circulates at high concentrations. Its biological end product, insoluble fibrin(ogen) or fibrin, can assume a diverse array of conformations with the ability to interact with numerous plasma proteins and cells and withstand biochemical and biomechanical disruption to facilitate wound healing. Quantitative and qualitative defects in fibrinogen or fibrin are associated with bleeding, thrombosis, inflammation, and diseases affected by these processes. Numerous studies investigating mechanisms by which fibrin(ogen) and fibrin contribute to health and disease have been published. This review for the 20th-anniversary series in the Journal of Thrombosis and Haemostasis summarizes interesting aspects of fibrin(ogen) biology, biochemistry, biophysics, and physiology and highlights exciting findings published in the past 2 decades.
纤维蛋白原是一种非常特别的分子。它体积大、结构复杂,且在血液中浓度很高。其生物终产物不溶性纤维蛋白原或纤维蛋白可以呈现出多种构象,能够与多种血浆蛋白和细胞相互作用,并能耐受生化和生物力学的破坏,从而促进伤口愈合。纤维蛋白原或纤维蛋白的定量和定性缺陷与出血、血栓形成、炎症和受这些过程影响的疾病有关。已经发表了许多研究纤维蛋白原和纤维蛋白在健康和疾病中作用机制的相关文章。在《血栓形成与止血杂志》创刊 20 周年系列文章中,本文对纤维蛋白原生物学、生物化学、生物物理学和生理学的有趣方面进行了总结,并重点介绍了过去 20 年中发表的令人兴奋的发现。